Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Hybrid Capture II testing for high-risk human papillomavirus DNA in the follow-up of women treated for high-grade cervical intraepithelial neoplasia.

Tan JH, Garland SM, Tabrizi SN, Moore EE, Danielewski JA, Quinn MA.

J Low Genit Tract Dis. 2013 Jul;17(3):308-14. doi: 10.1097/LGT.0b013e31826cd7c1.

PMID:
23552206
[PubMed - indexed for MEDLINE]
2.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Chinese.

PMID:
16635326
[PubMed - indexed for MEDLINE]
3.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

PMID:
16978225
[PubMed - indexed for MEDLINE]
4.

The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.

Recio FO, Sahai Srivastava BI, Wong C, Hempling RE, Eltabbakh GH, Piver MS.

Eur J Gynaecol Oncol. 1998;19(3):203-8.

PMID:
9641214
[PubMed - indexed for MEDLINE]
5.

Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.

Fait G, Kupferminc MJ, Daniel Y, Geva E, Ron IG, Lessing JB, Bar-Am A.

Gynecol Oncol. 2000 Nov;79(2):177-80.

PMID:
11063640
[PubMed - indexed for MEDLINE]
6.

Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.

Söderlund-Strand A, Rymark P, Andersson P, Dillner J, Dillner L.

J Clin Microbiol. 2005 Jul;43(7):3260-6.

PMID:
16000445
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.

Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.

J Pathol. 2001 Oct;195(3):300-6.

PMID:
11673826
[PubMed - indexed for MEDLINE]
8.

High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.

Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Garcia S, Campo E, Pahisa J, Ordi J.

Am J Obstet Gynecol. 2007 Oct;197(4):359.e1-6. Epub 2007 Aug 21.

PMID:
17714678
[PubMed - indexed for MEDLINE]
9.

Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.

Tiews S, Steinberg W, Schneider W, Hanrath C.

J Clin Virol. 2009 Nov;46 Suppl 3:S11-5. doi: 10.1016/S1386-6532(09)70295-1.

PMID:
20129068
[PubMed - indexed for MEDLINE]
10.

Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.

Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, Roth P, Lorincz AT, Gafni A.

CMAJ. 2000 Sep 19;163(6):701-7.

PMID:
11022584
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Managing atypical squamous cells of undetermined significance in Papanicolaou smears.

Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A.

J Reprod Med. 2001 Sep;46(9):799-805.

PMID:
11584480
[PubMed - indexed for MEDLINE]
12.

Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.

Ibáñez R, Moreno-Crespi J, Sardà M, Autonell J, Fibla M, Gutiérrez C, Lloveras B, Alejo M, Català I, Alameda F, Casas M, Bosch FX, de Sanjosé S.

BMC Infect Dis. 2012 Jan 26;12:25. doi: 10.1186/1471-2334-12-25.

PMID:
22280073
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.

JAMA. 2002 Oct 9;288(14):1749-57.

PMID:
12365959
[PubMed - indexed for MEDLINE]
14.

High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia.

Jeong NH, Lee NW, Kim HJ, Kim T, Lee KW.

J Obstet Gynaecol Res. 2009 Aug;35(4):706-11. doi: 10.1111/j.1447-0756.2008.00989.x.

PMID:
19751331
[PubMed - indexed for MEDLINE]
15.

[Usefulness of Hybrid Capture II detection of high-risk human papillomavirus in women with abnormal pap-smears of the uterine cervix].

Tena D, Garrido N, Menéndez JM, Delgado JJ, Romanyk J, González Mdel R, Zapico A, Beltrán M.

Enferm Infecc Microbiol Clin. 2005 Oct;23(8):474-8. Spanish.

PMID:
16185561
[PubMed - indexed for MEDLINE]
16.

Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions.

Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC.

Cancer Cytopathol. 2011 Aug 25;119(4):228-34. doi: 10.1002/cncy.20172. Epub 2011 Jul 5.

PMID:
21732551
[PubMed - indexed for MEDLINE]
17.

Improved rate of high-grade cervical intraepithelial neoplasia detection in human papillomavirus DNA hybrid capture testing.

Proca DM, Williams JD, Rofagha S, Tranovich VL, Keyhani-Rofagha S.

Anal Quant Cytol Histol. 2007 Aug;29(4):264-70.

PMID:
17879635
[PubMed - indexed for MEDLINE]
18.
19.

The significance of HPV in the follow-up period after treatment for CIN.

Gallwas J, Ditsch N, Hillemanns P, Friese K, Thaler C, Dannecker C.

Eur J Gynaecol Oncol. 2010;31(1):27-30.

PMID:
20349777
[PubMed - indexed for MEDLINE]
20.

A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities.

Andersson S, Dillner L, Elfgren K, Mints M, Persson M, Rylander E.

Acta Obstet Gynecol Scand. 2005 Oct;84(10):996-1000.

PMID:
16167918
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk